Discovery of Novel Recurrent Mutations and Clinically Meaningful Subgroups in Nodal Marginal Zone Lymphoma.
RNA sequencing
genetics
malignant lymphoma
marginal zone lymphoma
whole exome sequencing
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
23 Jun 2020
23 Jun 2020
Historique:
received:
19
05
2020
revised:
11
06
2020
accepted:
18
06
2020
entrez:
27
6
2020
pubmed:
27
6
2020
medline:
27
6
2020
Statut:
epublish
Résumé
Nodal marginal zone lymphoma (NMZL) is a rare B-cell neoplasm, the genetic and transcriptomic landscape of which are unclear. Using high-throughput sequencing for whole-exome and transcriptome, we investigated the genetic characteristics of NMZL in a discovery cohort (
Identifiants
pubmed: 32585984
pii: cancers12061669
doi: 10.3390/cancers12061669
pmc: PMC7352856
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Seoul National University (SNU) Invitation Program for Distinguished Scholar
ID : 0320170160 [2017-1312]
Organisme : Ministry of Education, Science and Technology
ID : NRF-2016R1D1A1B01015964
Organisme : Ministry of Education, Science and Technology
ID : NRF-2019R1F1A1061920
Références
Nat Med. 2018 May;24(5):679-690
pubmed: 29713087
Leukemia. 2014 Jun;28(6):1334-40
pubmed: 24296945
Nat Biotechnol. 2013 Mar;31(3):213-9
pubmed: 23396013
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
J Clin Oncol. 1999 Aug;17(8):2486-92
pubmed: 10561313
Nat Methods. 2015 May;12(5):453-7
pubmed: 25822800
Blood. 2013 Aug 15;122(7):1256-65
pubmed: 23699601
Bioinformatics. 2014 Feb 15;30(4):523-30
pubmed: 24336805
Blood. 2011 Feb 3;117(5):1595-604
pubmed: 21115979
Hematol Oncol. 2020 Feb 3;:
pubmed: 32012328
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Blood. 2016 Dec 8;128(23):2666-2670
pubmed: 27670424
Br J Haematol. 2007 Jan;136(2):301-4
pubmed: 17233821
PLoS One. 2016 Nov 9;11(11):e0165919
pubmed: 27829002
EMBO J. 1997 Mar 17;16(6):1413-26
pubmed: 9135156
Cancer Cell. 2012 Jun 12;21(6):723-37
pubmed: 22698399
Am J Surg Pathol. 2003 Jun;27(6):762-71
pubmed: 12766579
J Exp Med. 2013 Dec 16;210(13):2887-902
pubmed: 24323359
Leukemia. 2018 Nov;32(11):2412-2426
pubmed: 29556019
Leukemia. 2015 May;29(5):1177-85
pubmed: 25428260
Mod Pathol. 2012 May;25(5):651-60
pubmed: 22301699
J Biol Chem. 1996 Jul 26;271(30):18277-84
pubmed: 8663526
Cancer Discov. 2014 Jan;4(1):94-109
pubmed: 24265153
Leukemia. 1997 May;11(5):747-58
pubmed: 9180302
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Mod Pathol. 2018 Sep;31(9):1418-1428
pubmed: 29765142
Cancer Cell. 2014 Jan 13;25(1):91-101
pubmed: 24434212
CA Cancer J Clin. 2016 Nov 12;66(6):443-459
pubmed: 27618563
Cell. 2017 Oct 19;171(3):540-556.e25
pubmed: 28988769
Int J Clin Exp Pathol. 2014 Aug 15;7(9):5634-44
pubmed: 25337204
Blood. 2012 Jan 19;119(3):e9-e21
pubmed: 22110251
J Invest Dermatol. 2016 Jul;136(7):1490-1499
pubmed: 27039262
Blood. 2016 Sep 8;128(10):1362-73
pubmed: 27335277
Blood. 2004 Dec 1;104(12):3647-54
pubmed: 15191950
J Immunol. 2017 Jul 15;199(2):570-580
pubmed: 28615414
Histopathology. 2006 Jan;48(2):162-73
pubmed: 16405665
Genes (Basel). 2017 Apr 05;8(4):
pubmed: 28379189
Oncotarget. 2017 Mar 7;8(10):17038-17049
pubmed: 28152507
Front Biol (Beijing). 2014 Aug;9(4):269-282
pubmed: 25506356
J Exp Med. 2015 Jun 1;212(6):833-43
pubmed: 25987724
J Exp Med. 2012 Aug 27;209(9):1553-65
pubmed: 22891276
Nature. 2015 Oct 22;526(7574):519-24
pubmed: 26200345
Immunol Rev. 2006 Apr;210:67-85
pubmed: 16623765
Nature. 2013 May 2;497(7447):67-73
pubmed: 23636398